Consensus SMAIO

Stocks

ALSMA

FR0014005I80

Pharmaceuticals

Market Closed - Euronext Paris 16:55:00 02/10/2026 BST			5-day change	1st Jan Change
6.660 ^EUR	-1.48%		-6.46%	+6.56%

07-16	SMAIO Reports Group Sales Results for the Second Quarter and First Half Ended June 30, 2026	CI
07-16	SMAIO Continued Expansion of the Network in the United States, with 5 New Centers Added to the Network and 13 New Surgeons Who Have Performed Their First Implants	CI

Evolution of the Average Target: SMAIO

Evolution of the Target Price: SMAIO

Changes in Analyst Recommendations: SMAIO

dd65067667d66d88ba308e1425ece8.XWOpEVkoas8lIpkBF23640A5PWQjQuQhBvEW0UBloCE.aQ-RJSNRM6gXFe1uUgCIoHJ6SwFscq9Ob5Ymo3gf41QeJP98ExgTqk1X9g~27192184453c2306594698ea2aa018c8

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	SMAIO			-	-	+23.12%
	ELI LILLY AND COMPANY					+16.27%
	JOHNSON & JOHNSON					+9.08%
	ABBVIE INC.					+6.1%
	MERCK & CO., INC.					+7.94%
	ROCHE HOLDING AG					+8.57%
	NOVARTIS AG					+8.12%
	ASTRAZENECA PLC					+34.02%
	AMGEN INC.					-3%
	GILEAD SCIENCES, INC.					+9.61%
	Average					+11.98%
	Weighted average by Cap.					+11.42%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

OUTPERFORM

Number of Analysts

2

Last Close Price

6.660EUR

Average target price

8.200EUR

Spread / Average Target

+23.12%

High Price Target

8.200EUR

Spread / Highest target

+23.12%

Low Price Target

8.200EUR

Spread / Lowest Target

+23.12%

Analyst Consensus Detail

Consensus revision (last 18 months)

As early as today, start finding the best investment opportunities!

×